Skip to search.
 FTSE 100 Up 0.90%

Kite Pharma, Inc. (KITE)

-NasdaqGS
55.82 Up 1.38(2.53%) 28 Aug 21:00
|After Hours: : 56.00 Up 0.18 (0.32%) 28 Aug 23:30
Add to Portfolio
Prev Close:54.44
Open:54.11
Bid:53.50 x 100
Ask:56.10 x 500
1y Target Est:86.83
Beta:N/A
Earnings Date:12 Nov - 16 Nov (Est.)
Day's Range:52.51 - 55.89
52wk Range:23.85 - 89.21
Volume:617,682
Avg Vol (3m):1,163,630
Market Cap:2.44b
P/E (ttm):N/A
EPS (ttm):-1.42
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for KITE at this time.

Comparison

Symbol% ChgMkt Cap
KITEUp 2.53%2.44b
CELGUp 0.81%98.06b
PFEDown 1.80%201.43b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):326.86
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-2.07
Quarterly EPS Est (Sep-15) :-0.58
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Kite Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback